Out-of-pocket costs often keep pricey new cholesterol drugs out of reach, study finds
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients' out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Oct 4, 2017
0
0